Ultravist 370, sol inj 370 mg , fl 30 ml
7680469691976
CH-46969
V08AB05
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
768.86 MG | Substance | WIZUS |
|
(N/A)
|
370.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 38.10
Specialties list
Yes
Generic
No
SL addition date:
15/03/1994
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 46969
- Drug name
- Ultravist, Injektions-/Infusionslösung
- Galenic form
- LSIN
- ATC Code
- V08AB05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/05/1986
- Authorization expiration date
- 31/12/9999
- IT number
- 14.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ULTRAVIST sol inj 370 mg fl 30 ml
- Description (DE)
- ULTRAVIST Inj Lös 370 mg Fl 30 ml
- Narcotic (BTM)
- No